Product NDC: | 0006-3516 |
Proprietary Name: | PRIMAXIN |
Non Proprietary Name: | imipenem and cilastatin sodium |
Active Ingredient(s): | 500; 500 mg/100mL; mg/100mL & nbsp; imipenem and cilastatin sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0006-3516 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050587 |
Marketing Category: | NDA |
Start Marketing Date: | 19851126 |
Package NDC: | 0006-3516-59 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) > 100 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0006-3516-59 |
Proprietary Name | PRIMAXIN |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) > 100 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0006-3516 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | imipenem and cilastatin sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19851126 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | CILASTATIN SODIUM; IMIPENEM |
Strength Number | 500; 500 |
Strength Unit | mg/100mL; mg/100mL |
Pharmaceutical Classes | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] |